Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial
about
Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndromeProphylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infantsProphylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infantsEarly surfactant therapy with nasal continuous positive airway pressure or continued mechanical ventilation in very low birth weight neonates with respiratory distress syndromeAccounting for multiple births in neonatal and perinatal trials: systematic review and case study.Effects of gender on the health and development of medically at-risk infants.Implementation methods for delivery room management: a quality improvement comparison study.Does the use of primary continuous positive airway pressure reduce the need for intubation and mechanical ventilation in infants ≤32 weeks' gestation?Developmental expression of vasoactive and growth factors in human lung. Role in pulmonary vascular resistance adaptation at birth.Continuous positive airway pressure: early, late, or stay with synchronized intermittent mandatory ventilation?Impact of changes in perinatal care on neonatal respiratory outcome and survival of preterm newborns: an overview of 15 years.European consensus guidelines on the management of neonatal respiratory distress syndrome.Lung protective ventilatory strategies in very low birth weight infants.To tube or not to tube babies with respiratory distress syndrome.Application of continuous positive airway pressure in the delivery room: a multicenter randomized clinical trial.CPAP review.RDS--CPAP or surfactant or both.ELBW infants: to intubate or not to intubate in the delivery room?A comparison of the effects of invasive mechanic ventilation/surfactant therapy and non-invasive nasal-continuous positive airway pressure in preterm newborns.Sedation of newborn infants for the INSURE procedure, are we sure?Early versus delayed initiation of nasal continuous positive airway pressure for treatment of respiratory distress syndrome in premature newborns: A randomized clinical trial.Prophylactic administration of surfactant in extremely premature infantsTo intubate or not--that is the question: continuous positive airway pressure versus surfactant and extremely low birthweight infants.Factors affecting outcomes in very low birth weight infants treated electively with nasal continuous positive airway pressure.The use of continuous positive airway pressure in preterm babies with respiratory distress syndrome: a report from Baghdad, Iraq.Nasal high flow therapy in very low birth weight infants with mild respiratory distress syndrome: a single center experience.
P2860
Q24243075-98E8B9AD-EA52-4D53-BEC9-A6403054F177Q24246420-0C40FEEA-A913-432C-897A-9EA462BAFA15Q26471476-43892086-8BFD-432F-8B33-2CB998791E33Q33640615-E0300DD9-BB3F-4770-9141-6AD6CA508BA3Q33748656-B70CD36C-A91F-41BA-BB59-363923682378Q34181893-8A0D4942-D76D-413F-8A53-3DA3CA817FD3Q34411226-239AA604-7B0C-47A5-B2E0-4200E3C6ECCEQ35577063-A4EA9D2D-8397-4684-B210-DADE09DF11BFQ36092149-87DDE69C-5822-4B10-89C4-5E66BE88B04AQ36453813-19DDF2ED-9B20-41D5-9711-D30B7EC2E1DEQ36516093-0E31A7D5-308B-480F-99C8-C29694C72F29Q36811513-86147F4A-E61C-4301-86D9-85AEA191BA2BQ37150762-76AE0D3A-4164-4971-A09B-5339F9AC6AA7Q37462142-879E7C00-D085-4E0B-BEA4-9CF93476AA2EQ37696802-BD4F811A-C053-4DE3-A124-5B64D5C0A90BQ37968892-C2EFA1E6-FB65-489A-8BE6-5F1EBE520675Q37992221-1703B1D0-37B7-440A-9825-922B81690ADFQ38041602-91BF2690-6438-4A0E-9638-8DC960B4AD5FQ38600757-32F3C5AA-363E-49B9-8050-8B593945483BQ41859621-5E7D3C04-BC39-410E-A802-0B1144724816Q42012724-3FE1D927-84AB-478A-A79F-C5417CA3D833Q42236797-11D4C253-512F-41C5-8D04-1DECB572F17AQ43141829-A3FD34F9-D617-4D6C-9681-F1EB400A51D8Q44841399-CF1C5EBB-F560-4B14-960E-E3613C87DCE0Q46319387-94F230B0-47B4-466F-8EB0-F58169688483Q47098981-D5CDF4F6-DB28-48FB-9C51-A19D7DF35B43
P2860
Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Prophylactic nasal continuous ...... ised controlled clinical trial
@ast
Prophylactic nasal continuous ...... ised controlled clinical trial
@en
type
label
Prophylactic nasal continuous ...... ised controlled clinical trial
@ast
Prophylactic nasal continuous ...... ised controlled clinical trial
@en
prefLabel
Prophylactic nasal continuous ...... ised controlled clinical trial
@ast
Prophylactic nasal continuous ...... ised controlled clinical trial
@en
P2093
P2860
P356
P1476
Prophylactic nasal continuous ...... ised controlled clinical trial
@en
P2093
Colnaghi M
Mondello I
Orzalesi M
Salvioli GP
Tagliabue P
P2860
P304
P356
10.1136/ADC.2003.037010
P50
P577
2004-09-01T00:00:00Z